FindTrial
Sign In

An assessment of the efficacy of intrathecal morphine followed by intra-operative remifentanil infusion in the control of early post-operative pain relief in coronary artery bypass surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN55888454
Enrollment
Unknown
Registered
2005-09-30
Start date
2004-09-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Signs and Symptoms: Post operative pain Signs and Symptoms Post operative pain

Interventions

Each volunteer will be randomly allocated (using random number tables) to one of two groups: 1. Intrathecal morphine/Remifentanil group 2. Fentanyl/Alfentanil (control) group After transfer to the IT

Sponsors

Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with preserved myocardial function undergoing elective myocardial revascularisation having given written informed consent.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of intrathecal morphine and intravenous remifentanil against a standard analgesic technique in patients undergoing elective myocardial revascularisation.—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026